{
  "ticker": "GSS",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971293",
  "id": "02971293",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250722",
  "time": "0838",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250722/pdf/06m0f4gg2pywxw.pdf",
  "summary": "**Strategic Partnership Announcement Summary:**  \n\n- **Partnership Formed** with Tecan (automation) and Repado (IVD software) to develop fully integrated, automated infectious disease testing solutions.  \n- **Key Features** of the platform:  \n  - Integration of Tecan\u2019s liquid handling, Repado\u2019s regulatory-compliant software, and GSS\u2019s assay panels (Respiratory, GI, STIs).  \n  - Focus on automation, regulatory compliance (IVDR/FDA/ISO 13485), and scalability for labs.  \n- **Next Steps**: Early system access planned for select reference labs; expansion of GSS\u2019s 3base\u00ae assay menu underway.  \n\n*No capital markets, financial, or trading-sensitive information disclosed.*",
  "usage": {
    "prompt_tokens": 1243,
    "completion_tokens": 158,
    "total_tokens": 1401,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-21T22:58:38.571253"
}